Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mathew John Joseph"'
Autor:
F. Anthony Greco, Dana S. Thompson, Howard A. Burris, John D. Hainsworth, David R. Spigel, Dianna Shipley, Mathew John Joseph, M. Kelly Hagan
Publikováno v:
Cancer. 124:1982-1991
Background The best treatment for patients with advanced non-small cell lung cancer (NSCLC) and a poor performance status is not well defined. In this phase 2 trial, patients were randomized to receive treatment with either single-agent pemetrexed or
Autor:
Rami Owera, Howard A. Burris, Mathew John Joseph, Ruth E. Lamar, David R. Spigel, Johanna C. Bendell, Cassie M. Lane, D. S. Thompson, Chris Earwood, William Penley, Todd M. Bauer
Publikováno v:
Cancer Investigation. 34:265-270
AUY922 is an inhibitor of heat shock protein 90 (Hsp90). Hsp90 inhibitors induce kit degradation in preclinical gastrointestinal stromal tumor (GIST) models. This trial was designed to determine the progression-free survival (PFS) of patients with GI
Autor:
Michel E. Kuzur, Dianna Shipley, Mathew John Joseph, Laura Blakely, Cassie M. Lane, Mark Mainwaring, Chris Earwood, Johanna C. Bendell, Chandra Reddy, Ronald Blachly, Kirk Barnes
Publikováno v:
Cancer investigation. 35(6)
This phase-2 trial evaluated the efficacy of axitinib as maintenance therapy for patients with metastatic colorectal cancer (mCRC) following first-line treatment with FOLFOX/bevacizumab. Patients with mCRC received mFOLFOX/bevacizumab followed by axi
Autor:
Natalie R. Dickson, Janet A Matheny, Jeffrey Patton, Mathew John Joseph, Larry Edward Bilbrey, Stacey L Poole
Publikováno v:
Journal of Clinical Oncology. 37:278-278
278 Background: A rural oncology/hematology clinic located a far distance from the local community hospital was not able to provide hospital consultation support. Collaboration between the practice and the hospital resulted in a telemedicine pilot st
Publikováno v:
Journal of Clinical Oncology. 33:e14673-e14673
e14673 Background: Maintenance therapy is commonly used in the first-line treatment of mCRC. Maintenance therapy options include fluorouracil plus bev and bev single agent. Ax is an oral, potent, a...
Autor:
John D. Hainsworth, David R. Spigel, James D. Peyton, Mathew John Joseph, Sang Y. Huh, Edward K. Barnes, David Michael Waterhouse, Raven Quinn, Victor G. Gian, Davey B. Daniel, F. A. Greco, Howard A. Burris, Christopher F. Lobo
Publikováno v:
Journal of Clinical Oncology. 30:7035-7035
7035 Background: Adjuvant chemotherapy improves overall survival (OS) in patients (pts) with resected non small cell lung cancer (NSCLC). Bevacizumab and erlotinib improve survival in pts with advanced unresectable NSCLC. This randomized phase II mul
Publikováno v:
Journal of Cancer Research & Therapeutics. 2024 Supplement 1, Vol. 20, pS74-S79. 6p.
Publikováno v:
TIME Magazine; 11/7/1932, Vol. 20 Issue 19, p55-55, 1/2p
Rising from the Ashes explores continuing Native American political, social, and cultural survival and resilience with a focus on the life of Numiipuu (Nez Perce) anthropologist Archie M. Phinney. He lived through tumultuous times as the Bureau of In
Autor:
Judit Ágnes Kádár
Ethnic Positioning in Southwestern Mixed Heritage Writing explores how Southwestern writers and visual artists provide an opportunity to turn a stigmatized identity into a self-conscious holder of valuable assets, cultural attitudes, and memories. Th